Table 4.
The Serum Phospholipids Being Associated with the Risk of AD
| Variable | OR AD |
|---|---|
| Sph | 1.142343555 |
| LPE(20:4) | 1.002415184 |
| LPC(16:1) | 1.001474071 |
| PC(36:0) | 1.000258849 |
| PC(30:0) | 1.000220845 |
| LPC(16:0) | 1.000218341 |
| PC(38:3) | 1.000179719 |
| SM(24:1) | 1.000111326 |
| SM(16:0) | 1.000056987 |
| PC(32:1) | 1.000043308 |
| PC(38:2) | 1.000011827 |
| SM(12:0) | 1 |
| SM(14:0) | 1 |
| SM(18:1) | 1 |
| SM(20:0) | 1 |
| SM(22:0) | 1 |
| SM(24:0) | 1 |
| PC(28:0) | 1 |
| PC(30:1) | 1 |
| PC(34:1) | 1 |
| PC(34:2) | 1 |
| PC(36:1) | 1 |
| PC(36:2) | 1 |
| PC(36:4) | 1 |
| PC(38:1) | 1 |
| PC(38:4) | 1 |
| LPC(18:0) | 1 |
| LPC(18:1) | 1 |
| LPC(20:1) | 1 |
| LPC(20:3) | 1 |
| LPE(16:0) | 1 |
| LPE(18:1) | 1 |
| LPE(18:2) | 1 |
| Lyso-PAF | 1 |
| LPC(18:2) | 0.999835522 |
| SM(18:0) | 0.999788959 |
| PC(32:0) | 0.99943743 |
| LPC(20:4) | 0.998199605 |
| Cer(16:0) | 0.976745322 |
| LPE(18:0) | 0.954168832 |
Abbreviations: AD, atopic dermatitis; Cer, ceramide; LPC, lysophosphatidylcholine; LPE, lysophosphatidylethanolamine; PAF, platelet-activating factor; PC, phosphatidylcholine; SM, sphingomyelin; Sph, sphingosine.
We sought the serum phospholipids being associated with the risk of AD with L1 penalized logistic regression between AD and non-AD, which includes healthy controls and those with non-AD with atopic comorbidities.